(Q72742194)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Interferon activity and its characterization in the sera of patients with head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

author name string

M. Sato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

H. Yoshida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

T. Yanagawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

Y. Yura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

M. Urata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

M. Atsumi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

N. Furumoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

Y. Hayashi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

Y. Takegawa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205740

28 August 2023

language of work or name

English

0 references

publication date

1 October 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1239-1251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

28 October 2019

cites work

1

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Immunologic abnormalities in head and neck cancer.

28 August 2023

2

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Thymus-derived lymphocytes in patients with solid malignancies

28 August 2023

3

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy

28 August 2023

4

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

T-cell deficiency in patients with squamous cell cancer of the head and neck

28 August 2023

5

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

On the varied biologic effects of interferon

28 August 2023

6

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

The role of interferon in immediate hypersensitivity and autoimmune diseases

28 August 2023

8

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Inhibition by interferon of delayed-type hypersensitivity in the mouse

28 August 2023

9

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Natural killer cells: characteristics and regulation of activity

28 August 2023

10

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid

28 August 2023

12

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon

28 August 2023

13

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Interferon therapy in myelomatosis

28 August 2023

14

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

28 August 2023

15

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Interferon therapy in Hodgkin's disease. A case report

28 August 2023

16

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

28 August 2023

17

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Interferon therapy for neoplastic diseases in man in vitro and in vivo studies.

28 August 2023

19

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

Interferon nomenclature

21

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Immune Interferon in the Circulation of Patients with Autoimmune Disease

28 August 2023

22

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Detection of gamma interferon in the sera of patients with Behçet's disease

28 August 2023

23

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

28 August 2023

24

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

K562—A human erythroleukemic cell line

28 August 2023

25

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Plaque formation and isolation of pure lines with poliomyelitis viruses

28 August 2023

26

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Basis for the probit analysis of an interferon plaque reduction assay

28 August 2023

28

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Factors which influence inactivation of vesicular stomatitis virus by fresh human serum

28 August 2023

29

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

30

118

348

Welsch

1977

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Human serum lyses RNA tumour viruses

28 August 2023

31

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Inactivation of lysis of oncornaviruses by human serum

28 August 2023

32

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

A simplified isotope release assay for cell-mediated cytotoxicity against anchorage dependent target cells

28 August 2023

34

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Binding of Sheep Red Blood Cells to a Large Population of Human Lymphocytes

28 August 2023

36

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

37

121

1773

Kishimoto

1978

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

38

123

523

Carlo

1979

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Radioimmunoassay of 2 -microglobulin in human biological fluids

28 August 2023

39

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Peripheral K-lymphocyte population in head and neck cancer

28 August 2023

40

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole

28 August 2023

43

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Immunobiology in otolaryngology

28 August 2023

44

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

The Serum Levels and Urinary Excretion of β2-Microglobulin in Apparently Healthy Subjects

28 August 2023

45

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

46

129

1

Panem

1982

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

28 August 2023

47

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Interferon inhibits the generation of allospecific suppressor T lymphocytes

28 August 2023

48

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Modulation of the human in vitro antibody response by human leukocyte interferon preparations

28 August 2023

49

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Suppression of Mouse Antibody Producing Spleen Cells by Various Interferon Preparations

28 August 2023

50

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Interferon Preparations as Modifiers of Immune Responses

28 August 2023

51

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

52

113

1319

Brodeur

1974

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

53

127

2146

Härfast

1981

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

54

130

1215

Rodriguez

1983

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor

28 August 2023

55

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

28 August 2023

56

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

58

115

1191

Fujibayashi

1975

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

59

119

657

Theofilopoulos

1977

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Enhanced expression of β 2 -microglobulin and HLA antigens on human lymphoid cells by interferon

28 August 2023

60

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

61

111

603

Fanger

1983

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

Interferon (type-alpha and gamma) production by fresh and cryopreserved human mononuclear cells. Brief report

28 August 2023

62

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

63

128

2522

O'Malley

1982

1 reference

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19841001)54:7%3C1239::AID-CNCR2820540702%3E3.0.CO;2-R

28 August 2023

Identifiers

10.1002/1097-0142(19841001)54:7<1239::AID-CNCR2820540702>3.0.CO;2-R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205740%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference